Hernia Mesh Infection Claims

Why Mesh Infections Are Different from Normal Wound Infections

A normal soft tissue wound infection — one not involving a foreign implant — can typically be resolved with a course of appropriate antibiotics because the body's immune cells can access the infected tissue and the antibiotics can penetrate the infection. Mesh infections are fundamentally different because bacteria colonize the mesh surface and form biofilms — complex bacterial communities protected by a polysaccharide matrix that prevents antibiotic penetration and resists immune cell attack. Once a biofilm is established, the mesh effectively becomes a permanent reservoir of infection that antibiotics can suppress but rarely eliminate.

Mesh Design and Infection Risk

Scientific literature has established that mesh pore size directly affects infection risk. Mesh with pores smaller than 75 micrometers in diameter creates protected niches that macrophages and neutrophils — the immune cells that fight bacteria — cannot enter because they are too large. These protected niches allow bacteria to proliferate beyond the reach of both the immune system and antibiotics. Heavyweight, small-pore mesh products (including some Bard designs) are associated with higher infection rates than large-pore, lightweight mesh in comparative studies. Plaintiffs allege that manufacturers chose smaller pore architectures for handling and structural reasons while knowing they created elevated infection risk.

Clinical Course of Mesh Infection

Mesh infections may present acutely within weeks of surgery or as a delayed chronic infection months or years after implantation. Acute presentations involve wound redness, swelling, purulent drainage, and fever requiring prompt medical attention. Chronic presentations may involve a persistent draining sinus tract — a tunnel from the infected mesh to the skin surface — with intermittent drainage that the patient and physician may initially mistake for a simple wound healing problem. The diagnosis is established by wound culture, imaging (CT scan or MRI showing fluid collection), and clinical correlation. Treatment typically begins with prolonged antibiotic therapy followed by surgical exploration and ultimately explantation when antibiotics fail.

Sepsis and Life-Threatening Mesh Infection

In the most severe cases, mesh infection progresses to sepsis — a systemic inflammatory response to infection that causes organ dysfunction and can rapidly become life-threatening. Sepsis from mesh infection requires ICU-level care, broad-spectrum intravenous antibiotics, and emergency surgical debridement and mesh removal. Mortality from sepsis in surgical patients exceeds 20 percent in some cohorts. Survivors of septic mesh infection may have permanent organ damage, and the combined medical costs of sepsis treatment plus mesh explantation surgery can exceed $200,000. These cases represent the highest-value claims in hernia mesh litigation.